Last Updated : March 5, 2009
Details
FilesGeneric Name:
Desvenlafaxine succinate
Project Status:
Complete
Therapeutic Area:
Depressive, Major Disorder (MDD)
Manufacturer:
Wyeth Canada
Brand Name:
Pristiq
Project Line:
Reimbursement Review
Project Number:
SR0159-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Depressive, Major Disorder (MDD)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : March 5, 2009